Need Help? Chat Now With a Live Representative!

News

Flexible and Lightweight CRO Education: ARG Chrysalis Leads The Way

Flexible and Lightweight CRO Education: ARG Chrysalis Leads The Way

One of the main reasons why ARG has consistently produced excellent clinical trial work over the years has been because […]

January 28, 2018
ARG Has Big Plans For Rare Disease Day

ARG Has Big Plans For Rare Disease Day

Rare Disease Day is February 28th, and ARG is planning to participate in several ways. Locally, we are planning to […]

January 15, 2018
Prometic Announces FDA Acceptance of its BLA For Ryplazim

Prometic Announces FDA Acceptance of its BLA For Ryplazim

• Prescription Drug User Fee Act (PDUFA) action date is set for April 14, 2018• Ryplazim™ previously granted Fast Track, […]

October 13, 2017
Atlantic Research Group Forms Rare Disease Strategic Advisory Board to Accelerate Novel Medicines

Atlantic Research Group Forms Rare Disease Strategic Advisory Board to Accelerate Novel Medicines

Atlantic Research Group forms Rare Disease Strategic Advisory Board to accelerate novel medicines. Learn about this collaboration between patient advocacy […]

August 12, 2017
Why “CRA-centricity” Matters For Your Rare Disease Clinical Trial

Why “CRA-centricity” Matters For Your Rare Disease Clinical Trial

Rare disease clinical trials also require extraordinary customer service—sometimes even including package delivery. In one case, each treatment dose cost […]

August 4, 2017
ARG to attend the BIO International Convention

ARG to attend the BIO International Convention

ARG to attend the BIO International Convention from 19-22 June 2017 in San Diego, CA. More Information

May 10, 2017
GO TO TOP